Royal Bank of Canada’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.09M | Buy |
2,379,088
+1,856,201
| +355% | +$3.19M | ﹤0.01% | 2488 |
|
|
2025
Q1 | $1.74M | Buy |
522,887
+322,680
| +161% | +$1.07M | ﹤0.01% | 2759 |
|
|
2024
Q4 | $1.48M | Sell |
200,207
-8,957
| -4% | -$66.3K | ﹤0.01% | 2847 |
|
|
2024
Q3 | $1.96M | Buy |
209,164
+72,830
| +53% | +$684K | ﹤0.01% | 2666 |
|
|
2024
Q2 | $1.09M | Buy |
136,334
+37,189
| +38% | +$298K | ﹤0.01% | 3041 |
|
|
2024
Q1 | $1.47M | Buy |
99,145
+17,164
| +21% | +$254K | ﹤0.01% | 2805 |
|
|
2023
Q4 | $667K | Buy |
81,981
+39,961
| +95% | +$325K | ﹤0.01% | 3517 |
|
|
2023
Q3 | $191K | Buy |
42,020
+18,280
| +77% | +$83.1K | ﹤0.01% | 4370 |
|
|
2023
Q2 | $168K | Buy |
23,740
+12,550
| +112% | +$88.8K | ﹤0.01% | 4483 |
|
|
2023
Q1 | $68K | Sell |
11,190
-12,390
| -53% | -$75.3K | ﹤0.01% | 5071 |
|
|
2022
Q4 | $150K | Buy |
23,580
+18,514
| +365% | +$118K | ﹤0.01% | 4679 |
|
|
2022
Q3 | $48K | Buy |
5,066
+1,787
| +54% | +$16.9K | ﹤0.01% | 5270 |
|
|
2022
Q2 | $36K | Sell |
3,279
-3,175
| -49% | -$34.9K | ﹤0.01% | 5396 |
|
|
2022
Q1 | $107K | Sell |
6,454
-461
| -7% | -$7.64K | ﹤0.01% | 5128 |
|
|
2021
Q4 | $132K | Sell |
6,915
-1,034
| -13% | -$19.7K | ﹤0.01% | 5200 |
|
|
2021
Q3 | $195K | Sell |
7,949
-26,324
| -77% | -$646K | ﹤0.01% | 4701 |
|
|
2021
Q2 | $892K | Buy |
34,273
+31,921
| +1,357% | +$831K | ﹤0.01% | 3355 |
|
|
2021
Q1 | $75K | Sell |
2,352
-3,825
| -62% | -$122K | ﹤0.01% | 5151 |
|
|
2020
Q4 | $286K | Sell |
6,177
-170,790
| -97% | -$7.91M | ﹤0.01% | 4068 |
|
|
2020
Q3 | $5.83M | Buy |
176,967
+21,536
| +14% | +$709K | ﹤0.01% | 1647 |
|
|
2020
Q2 | $4.27M | Buy |
155,431
+48,358
| +45% | +$1.33M | ﹤0.01% | 1803 |
|
|
2020
Q1 | $3.21M | Buy |
107,073
+73,514
| +219% | +$2.2M | ﹤0.01% | 1838 |
|
|
2019
Q4 | $929K | Buy |
33,559
+12,664
| +61% | +$351K | ﹤0.01% | 2973 |
|
|
2019
Q3 | $380K | Buy |
20,895
+19,295
| +1,206% | +$351K | ﹤0.01% | 3481 |
|
|
2019
Q2 | $39K | Sell |
1,600
-500
| -24% | -$12.2K | ﹤0.01% | 4700 |
|
|
2019
Q1 | $20K | Buy |
2,100
+565
| +37% | +$5.38K | ﹤0.01% | 4884 |
|
|
2018
Q4 | $14K | Sell |
1,535
-2,155
| -58% | -$19.7K | ﹤0.01% | 4980 |
|
|
2018
Q3 | $42K | Buy |
3,690
+2,118
| +135% | +$24.1K | ﹤0.01% | 4720 |
|
|
2018
Q2 | $20K | Sell |
1,572
-1,504
| -49% | -$19.1K | ﹤0.01% | 4947 |
|
|
2018
Q1 | $52K | Buy |
3,076
+2,008
| +188% | +$33.9K | ﹤0.01% | 4437 |
|
|
2017
Q4 | $9K | Sell |
1,068
-5,273
| -83% | -$44.4K | ﹤0.01% | 5147 |
|
|
2017
Q3 | $50K | Buy |
6,341
+5,490
| +645% | +$43.3K | ﹤0.01% | 4677 |
|
|
2017
Q2 | $6K | Sell |
851
-1,977
| -70% | -$13.9K | ﹤0.01% | 5227 |
|
|
2017
Q1 | $21K | Sell |
2,828
-995
| -26% | -$7.39K | ﹤0.01% | 4917 |
|
|
2016
Q4 | $26K | Buy |
3,823
+2,968
| +347% | +$20.2K | ﹤0.01% | 4866 |
|
|
2016
Q3 | $7K | Buy |
855
+100
| +13% | +$819 | ﹤0.01% | 5121 |
|
|
2016
Q2 | $6K | Buy |
755
+200
| +36% | +$1.59K | ﹤0.01% | 5176 |
|
|
2016
Q1 | $3K | Sell |
555
-59
| -10% | -$319 | ﹤0.01% | 5332 |
|
|
2015
Q4 | $5K | Sell |
614
-1,529
| -71% | -$12.5K | ﹤0.01% | 5382 |
|
|
2015
Q3 | $12K | Sell |
2,143
-497
| -19% | -$2.78K | ﹤0.01% | 5210 |
|
|
2015
Q2 | $24K | Buy |
2,640
+2,440
| +1,220% | +$22.2K | ﹤0.01% | 5115 |
|
|
2015
Q1 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 5449 |
|